Search

Author/Creator Wilson, Timothy R.

2. MET gene amplification is a mechanism of resistance to entrectinib in ROS1+ NSCLC. Issue 21 (13th September 2022)

Authors:
Tyler, Logan C.; Le, Anh T.; Chen, Nan; Nijmeh, Hala; Bao, Liming; Wilson, Timothy R.; Chen, David; Simmons, Brian; Turner, Kristen M.; Perusse, Dean; Kasibhatla, Shailaja; Christiansen, Jason; Dudek, Arkadiusz Z.; Doebele, Robert C.
Journal:
Thoracic cancer
Issue:
Volume 13:Issue 21(2022)
Page Start:
3032
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Pre‐ and post‐treatment blood‐based genomic landscape of patients with ROS1 or NTRK fusion‐positive solid tumours treated with entrectinib. Issue 10 (22nd April 2022)

Authors:
Dziadziuszko, Rafal; Hung, Tiffany; Wang, Kun; Choeurng, Voleak; Drilon, Alexander; Doebele, Robert C.; Barlesi, Fabrice; Wu, Charlie; Dennis, Lucas; Skoletsky, Joel; Woodhouse, Ryan; Li, Meijuan; Chang, Ching‐Wei; Simmons, Brian; Riehl, Todd; Wilson, Timothy R.
Journal:
Molecular oncology
Issue:
Volume 16:Issue 10(2022)
Page Start:
2000
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Updated Integrated Analysis of the Efficacy and Safety of Entrectinib in Locally Advanced or Metastatic ROS1 Fusion–Positive Non–Small-Cell Lung Cancer. Issue 11 (10th April 2021)

Authors:
Dziadziuszko, Rafal; Krebs, Matthew G.; De Braud, Filippo; Siena, Salvatore; Drilon, Alexander; Doebele, Robert C.; Patel, Manish R.; Cho, Byoung Chul; Liu, Stephen V.; Ahn, Myung-Ju; Chiu, Chao-Hua; Farago, Anna F.; Lin, Chia-Chi; Karapetis, Christos S.; Li, Yu-Chung; Day, Bann-mo; Chen, David; ...
Journal:
Journal of clinical oncology
Issue:
Volume 39:Issue 11(2021)
Page Start:
1253
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗